Seelos Therapeutics, Inc. (SEELQ) — Net Asset Momentum
Seelos Therapeutics, Inc. (SEELQ) recorded a net asset momentum of -215.8% as of December 2023, with net assets of $-33.51 Million USD. Net Asset Momentum measures the year-over-year percentage change in net assets (total assets minus total liabilities), indicating how rapidly the company is building or eroding its equity base. See Seelos Therapeutics, Inc. book value and equity for net asset value and shareholders' equity analysis.
YoY Momentum
Current Net Assets
Years of Data
Country
Seelos Therapeutics, Inc. Net Asset Momentum (2020–2023)
This chart tracks Seelos Therapeutics, Inc.'s year-over-year net asset growth across 4 annual reporting periods from 2020 to 2023. The most recent momentum reading is -215.8%, with net assets of $-33.51 Million USD as of December 2023. For live market cap and overall valuation, see Seelos Therapeutics, Inc. (SEELQ) total market value.
Annual Net Asset History for Seelos Therapeutics, Inc. (2020–2023)
The table below shows the complete annual net asset history for Seelos Therapeutics, Inc. from 2020 to 2023, covering 4 yearly periods. Each row includes total assets, total liabilities, net assets, and the year-over-year momentum figure for that period. Check Seelos Therapeutics, Inc. tangible book value ratio to evaluate the tangible quality of the company's equity base.
| Year | Net Assets (USD) | Total Assets | Total Liabilities | YoY Momentum |
|---|---|---|---|---|
| 2023 | $-33.51 Million | $5.42 Million | $38.93 Million | ▼ -215.8% |
| 2022 | $-10.61 Million | $22.75 Million | $33.36 Million | ▼ -118.5% |
| 2021 | $57.32 Million | $83.50 Million | $26.18 Million | ▲ +2128.7% |
| 2020 | $2.57 Million | $17.49 Million | $14.92 Million | — |